Systemic beta-blocker therapy and brimonidine and timolol.
Coulibaly
R
R
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000068438:Brimonidine Tartrate; D002986:Clinical Trials as Topic; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D009798:Ocular Hypertension / Q000188:drug therapy; D009883:Ophthalmic Solutions; D011810:Quinoxalines / Q000627:therapeutic use*; D012449:Safety; D013999:Timolol / Q000627:therapeutic use*
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; D013999:Timolol